More about Aether

Aether uses its state of the art platform to rapidly engineer enzymes, enabling its customers to manufacture complex and novel products at fractional cost. It is the first company capable of searching sequence space to find novel biocatalysts. The company’s technology can design enzymes for an ever-increasing range of chemistries. Its robotic factory runs millions of experiments to index sequence space and its algorithms search trillions of enzymes.

Aether in the news